Daebonglsco.,Ltd

078140 KRX Pharmaceuticals Pharmaceuticals
KOSDAQ
₩7,530.00
-0.53%
Delayed · cached 15 min

Fair value analysis

078140
Daebonglsco.,Ltd
Pharmaceuticals›Pharmaceuticals
₩7,530.00
Close used for this calculation
₩14,599.05Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
56/100
Profitability17/25
Returns11/25
Balance Sheet10/25
Efficiency18/25
Growth14/25
Good
Quality radar
56Prof.17/25Ret.11/25Eff.18/25B.Sht10/25Growth14/25

Consensus fair value

₩14,599.05
Below FV
▲ +93.9% against the close used
Model range ₩3,635.17 – ₩38,426.45
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩3,635.17Fair value₩14,599.05Bull₩38,426.45
FairClose
52-week traded range
52W low ₩7,020.0052W high ₩8,600.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Daebonglsco.,Ltd closed at ₩7,530.00, 48.4% below the consensus fair value of ₩14,599.05 drawn from 9 valuation models.

Financial DNA score 56/100 — Good. P/E of 8.2x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩18,241.25
+142.2%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₩16,384.47
+117.6%
√(22.5 × EPS × BVPS)
EPS=919, BVPS=12982.76
Graham Formula
₩38,426.45
+410.3%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=11.4%, FD=3.3%
P/E Fair Value
₩18,380.00
+144.1%
EPS × 20x (sector P/E)
EPS=919, Sector P/E=20x
Peter Lynch (PEG)
₩10,504.17
+39.5%
EPS × Growth% (PEG = 1 is fair)
EPS=919, g=11.4%
EV/EBITDA
₩7,769.72
+3.2%
(EBITDA × 15.7x − Net Debt) ÷ Shares
EBITDA=10.94B
Book Value (P/B)
₩3,635.17
-51.7%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=12982.76, ROE=7.1%, g=6%, r=10%
Reverse DCF
₩7,530.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -5.1% | Historical: 11.4%
Margin of Safety
₩17,143.53
+127.7%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=22858.04, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.